Fondaparinux-associated Thrombocytopenia
- PMID: 33679958
- PMCID: PMC7931326
- DOI: 10.12669/pjms.37.2.3522
Fondaparinux-associated Thrombocytopenia
Abstract
Heparin-induced thrombocytopenia (HIT) is an immune-mediated condition causing thrombocytopenia and paradoxical thrombosis after exposure to heparin or low-molecular-weight heparin. It has been rarely reported by Fondaparinux, an artificial pentasaccharide similar to heparin. This manuscript presents a case of HIT associated with fondaparinux use.
Keywords: Factor Xa inhibitor; Fondaparinux-associated thrombocytopenia; HIT.
Copyright: © Pakistan Journal of Medical Sciences.
Conflict of interest statement
Conflict of interests: None.
References
-
- Gruel Y, De Maistre E, Pouplard C, Mullier F, Susen S, Roullet S, et al. Diagnosis and management of heparin-induced thrombocytopenia. Anaesth Crit Care Pain Med. 2020;39(2):291–310. - PubMed
-
- Kounis NG, Koniari I, Soufras GD, Tsigkas G, Plotas P, Davlouros P, et al. The paradox of heparin induced thrombocytopenia-thrombosis, the role of fondaparinux and the need for new therapeutic strategies. Int Angiol. 2020;39(4):350–351. doi:10.23736/S0392-9590.20.04364-3. - PubMed
-
- Khodabandeh S, Biancari F, Kinnunen EM, Mariscalco G, Airaksinen J, Gherli R, et al. Perioperative Bleeding in Patients With Acute Coronary Syndrome Treated With Fondaparinux Versus Low-Molecular-Weight Heparin Before Coronary Artery Bypass Grafting. Am J Cardiol. 2019;123(4):565–570. doi:10.1016/j.amjcard.2018.11.028. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources